Overview

This protocol helps establish patient-derived xenograft (PDX) models of anaplastic thyroid carcinoma (ATC) and head and neck squamous cell carcinoma (HNSCC), which better reflect tumor heterogeneity and molecular diversity. The technique is user-friendly and has a high success rate, making it suitable for various PDX models.

Key Study Components

Area of Science

Oncology
Translational Medicine
Pathology

Background

PDX models are becoming standard in translational oncology.
They provide insights into tumor behavior and treatment responses.
Understanding tumor heterogeneity is crucial for personalized medicine.
ATC and HNSCC are aggressive cancers with poor prognosis.

Purpose of Study

To establish reliable PDX models for ATC and HNSCC.
To enhance the understanding of tumor biology.
To facilitate drug sensitivity screening for personalized treatment.

Methods Used

Collection of tumor samples in sterile HTK solution.
Disinfection of samples with 75% alcohol.
Transfer and preparation of tumor tissue in saline.
Cutting tumor samples into small pieces for implantation.

Main Results

Successful establishment of PDX models reflecting tumor diversity.
High success rate in model creation.
Potential for application in drug sensitivity testing.
Detailed methodology provided for reproducibility.

Conclusions

The established PDX models are valuable for research and treatment strategies.
Attention to detail is crucial for successful implementation.
This technique can be adapted for other cancer types.

Frequently Asked Questions

What are PDX models?

PDX models are patient-derived xenografts that mimic the original tumor environment in a host organism.

Why are PDX models important?

They provide insights into tumor heterogeneity and help predict clinical outcomes.

How are tumor samples prepared for PDX models?

Tumor samples are collected, disinfected, and cut into small pieces for implantation.

What cancers are studied using this protocol?

The protocol focuses on anaplastic thyroid carcinoma and head and neck squamous cell carcinoma.

Can this technique be used for other cancers?

Yes, the technique can be adapted for various other PDX models.

What is the success rate of this technique?

The technique has a high success rate in establishing PDX models.

Institution - Sichuan Kangcheng Biotech Co.

Articles Published in JoVE